| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $51.7M | — | +3.4% |
| R&D Expense | $28.4M | — | -20.4% |
| SG&A Expense | $68.4M | — | +36.5% |
| Operating Income | -$50.2M | — | -22.4% |
| Pre-tax Income | -$48.4M | — | -29.6% |
| Income Tax | $143K | — | +101.8% |
| Net Income | -$48.6M | — | -64.7% |
| EPS (Basic) | -$0.82 | — | -64.0% |
| EPS (Diluted) | -$0.82 | — | -64.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $54.0M | -36.3% | -51.7% |
| Accounts Receivable | $56.9M | +4.2% | +27.5% |
| Inventory | $1.7M | -8.3% | -11.6% |
| Current Assets | $293.2M | -15.6% | -28.1% |
| Total Assets | $433.5M | -11.3% | -31.4% |
| Current Liabilities | $135.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$50.2M | — | -51.5% |
| Capital Expenditures | $221K | — | -49.3% |
| Investing Cash Flow | $20.2M | — | -53.9% |
| Financing Cash Flow | -$776K | — | +41.4% |
| Free Cash Flow | -$50.4M | — | -50.2% |
| +30.5% |
| Total Liabilities | $152.8M | -5.6% | +26.8% |
| Stockholders' Equity | $280.8M | -14.2% | -45.1% |